BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2000
View Archived Issues
Sepracor completes large-scale U.S. efficacy study of (S)-zopiclone
Read More
Orally active ester prodrug of alphavbeta3 antagonist effective in rat model of osteoporosis
Read More
SmithKline Beecham to divest Kytril, Famvir and Vectavir/Denavir
Read More
Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer
Read More
Novel treatment for asthma --an IL-4/IL-13 receptor antagonist-- characterized at ERS meeting
Read More
Ebselen as a new therapeutic agent for asthma
Read More
One-year treatment with UT-15 improves hemodynamics, exercise tolerance in PPH
Read More
ACS news: selective inhibitors of ICAM-1/E-selectin expression exerting antiinflammatory activity
Read More
XTL Biopharmaceuticals and Hybrigenics to codevelop novel HCV therapeutics
Read More
R&D at Pharmacia in the area of CETP inhibitors discussed at ACS meeting
Read More
Serono acquires exclusive rights to Cetrotide; U.S. launch planned
Read More
Noncompetitive dihydrophthalazine AMPA receptor antagonists synthesized at Annovis
Read More
Actelion continues development of tezosentan and bosentan as planned
Read More
ZD-6021: a potent, orally active tachykinin receptor antagonist
Read More
Phylos achieves key milestones in Amgen drug discovery collaboration
Read More
Supratek's SP-1017 shown to significantly increase gene expression
Read More
Aventis characterizes potential novel antiasthmatic agent
Read More
Sequenom and PHRI to develop high-speed diagnostic tests for MDR tuberculosis
Read More
Ortec's treatment for venous ulcers continues to demonstrate superiority
Read More
PARP inhibitors reportedly useful in combination with cytotoxic agents
Read More
Ranbaxy's new cell adhesion inhibitors with antiinflammatory activity
Read More
Amides with cholinergic activity and their use disclosed by Fujisawa
Read More
Endothelin receptor antagonists designed by Roche
Read More
MEK inhibitors and their use described in recent patents
Read More
DuPont patent describes new HIV protease inhibitors
Read More
New antitumor compound from Banyu produced by microorganism
Read More